Squarepoint’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Sell
21,427
-1,174,148
-98% -$105M ﹤0.01% 2245
2025
Q4
$94.5M Buy
1,195,575
+994,017
+493% +$77.9M 0.1% 221
2025
Q3
$16.1M Buy
201,558
+179,766
+825% +$15.3M 0.02% 851
2025
Q2
$1.98M Sell
21,792
-636,078
-97% -$58.1M ﹤0.01% 2117
2025
Q1
$61.6M Sell
657,870
-388,041
-37% -$34.7M 0.07% 276
2024
Q4
$95.1M Buy
1,045,911
+648,626
+163% +$61.9M 0.09% 200
2024
Q3
$41.2M Buy
397,285
+36,277
+10% +$3.7M 0.06% 298
2024
Q2
$35M Sell
361,008
-377,259
-51% -$34.8M 0.06% 352
2024
Q1
$66.5M Sell
738,267
-714,766
-49% -$60.6M 0.11% 174
2023
Q4
$116M Buy
1,453,033
+1,390,085
+2,208% +$105M 0.22% 69
2023
Q3
$4.48M Sell
62,948
-293,944
-82% -$22M 0.01% 1247
2023
Q2
$27.5M Buy
356,892
+305,790
+598% +$23.7M 0.08% 262
2023
Q1
$3.84M Buy
51,102
+37,737
+282% +$2.81M 0.02% 1028
2022
Q4
$1.05M Sell
13,365
-293,206
-96% -$22M ﹤0.01% 1788
2022
Q3
$21.5M Buy
+306,571
New +$24M 0.11% 202
2022
Q2
Sell
-8,133
Closed -$617K 2933
2022
Q1
$617K Sell
8,133
-15,807
-66% -$1.25M ﹤0.01% 1888
2021
Q4
$2.04M Buy
23,940
+7,486
+45% +$585K 0.01% 1246
2021
Q3
$1.24M Sell
16,454
-562,671
-97% -$44.7M ﹤0.01% 1452
2021
Q2
$47.1M Sell
579,125
-13,821
-2% -$1.13M 0.18% 103
2021
Q1
$46.7M Buy
592,946
+565,407
+2,053% +$44.3M 0.27% 51
2020
Q4
$2.35M Buy
+27,539
New +$2.28M 0.02% 859
2020
Q3
Sell
-55,825
Closed -$4.09M 2513
2020
Q2
$4.09M Sell
55,825
-224,560
-80% -$16M 0.07% 397
2020
Q1
$18.6M Sell
280,385
-231,516
-45% -$16.3M 0.48% 28
2019
Q4
$35.2M Buy
511,901
+347,158
+211% +$23.7M 0.21% 72
2019
Q3
$12.1M Sell
164,743
-200,839
-55% -$14.6M 0.11% 234
2019
Q2
$26.2M Sell
365,582
-975,459
-73% -$69.2M 0.26% 87
2019
Q1
$91.9M Buy
1,341,041
+864,277
+181% +$55.8M 0.97% 6
2018
Q4
$28.4M Buy
476,764
+444,170
+1,363% +$27.8M 0.33% 44
2018
Q3
$2.18M Sell
32,594
-12,017
-27% -$800K 0.03% 690
2018
Q2
$2.89M Buy
44,611
+35,035
+366% +$2.29M 0.04% 527
2018
Q1
$686K Sell
9,576
-898
-9% -$64.6K 0.01% 963
2017
Q4
$790K Sell
10,474
-16,726
-61% -$1.22M 0.01% 944
2017
Q3
$1.98M Sell
27,200
-89,590
-77% -$6.46M 0.04% 505
2017
Q2
$8.66M Sell
116,790
-78,384
-40% -$5.82M 0.17% 144
2017
Q1
$14.3M Buy
195,174
+176,182
+928% +$12.3M 0.39% 54
2016
Q4
$1.24M Buy
+18,992
New +$1.3M 0.05% 428
2016
Q3
Sell
-28,313
Closed -$2.07M 1036
2016
Q2
$2.07M Buy
+28,313
New +$2.02M 0.13% 183
2016
Q1
Sell
-7,172
Closed -$478K 1202
2015
Q4
$478K Buy
+7,172
New +$477K 0.05% 564

Other funds holding CL

Squarepoint's CL Position: Q1 2026 in Review

Squarepoint reduced its Colgate-Palmolive (CL) stake by 98% in Q1 2026, selling an estimated $105M and leaving 21,427 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Squarepoint first reported a position in CL in Q4 2015 and has held it in 38 quarters since. The position peaked at $116M in Q4 2023. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Squarepoint held 21,427 shares of Colgate-Palmolive worth $1.83M as of Q1 2026.
  • Squarepoint sold 1,174,148 Colgate-Palmolive shares in Q1 2026, an estimated $105M.
  • Colgate-Palmolive made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2245 holding.
  • Squarepoint first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 38 quarters since.
  • Squarepoint's Colgate-Palmolive position peaked at $116M in Q4 2023.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.